Insider Cluster (2 insiders) ·Filed Jun 12, 2026

INDV

Indivior Pharmaceuticals, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $2.1M total
Actionable Insight • Neutral

The cluster is small relative to market cap and insider sales are typically liquidity-driven. Monitor for any upcoming earnings or regulatory catalysts that could explain the timing, but no immediate action warranted given the sub-0.1% proportionality.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
INDV ▼ -9.45% at T+60d
NEUTRAL call ✗ call lost -9.45% · α vs SPY -10.46% · entry $38.40 → $34.77
Entry anchored
Jun 12, 03:59 PM ET
via exchange tick
T+1d
-1.02%
call -1.02% · α -0.42%
$38.01
settled 4mo ago
T+5d
-0.21%
call -0.21% · α +1.17%
$38.32
settled 3mo ago
T+20d
+4.71%
call +4.71% · α +5.46%
$40.21
settled 3mo ago
T+60d
-9.45%
call -9.45% · α -10.46%
$34.77
settled 23d ago

Price Chart

Loading chart...

Executive Summary

Two senior insiders at Indivior (CFO and CSO) sold a combined $2.06M in open-market sales over a 4-day window. While the dollar amount is modest relative to the $4.8B market cap (~0.04%), the involvement of both the CFO and CSO in a tight cluster warrants attention, though insider sales are generally less predictive than buys per academic literature.

Key Financial Metrics

Direction
selling
Total Value
$2.1M
Insiders
2

Key Facts

  • CFO Ryan Preblick sold 36,000 shares for $1.36M on 2026-06-08 at $37.70
  • CSO Christian Heidbreder sold 18,586 shares for $707K on 2026-06-11 at $38.06
  • Total insider sales of $2.06M represent ~0.04% of INDV's $4.8B market cap
  • No insider purchases were reported in the cluster window

Financial Impact

Total insider sales of $2.06M, representing ~0.04% of market cap — well below the 0.1% materiality threshold

insider ownership

Risk Factors

  • Insider sales may signal reduced conviction ahead of a catalyst, though the dollar amount is trivial relative to market cap
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INDV-1781295165685
18 reports for INDV
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +21.73%Apr 24, 2026
Filters
Rows
Reports for INDV — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
EFFECT
NEUTRAL ★ 4/10
$34.47 $35.53▲ +3.08%▲ +2.97%$35.71 (+3.60%)
Aug 28, 2026
4w ago
S-4
NEUTRAL ★ 6/10
$34.93 $34.32▼ −1.75%▼ −1.60%$35.71 (+2.23%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 7/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$40.51 $40.22▼ −0.72%▼ −1.19%$35.71 (−11.85%)
Jun 12, 2026
16w ago
Insider Cluster
NEUTRAL ★ 4/10
$38.40 $38.32▼ −0.21%▲ +1.17%$35.71 (−7.01%)
May 15, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$36.54 $37.81▲ +3.48%▲ +1.86%$35.71 (−2.27%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$38.98 $38.84▼ −0.36%▼ −3.30%$35.71 (−8.39%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 12, 2026